Elsa Jerre1, Mona Bungum1, Donald Evenson2, Aleksander Giwercman3. 1. Department of Translational Medicine, Lund University, Malmö, Sweden. 2. SCSA Diagnostics, Inc., Brookings, South Dakota. 3. Department of Translational Medicine, Lund University, Malmö, Sweden. Electronic address: aleksander.giwermcan@med.lu.se.
Abstract
OBJECTIVE: To determine whether high DNA stainability (HDS), as assessed by the sperm chromatin structure assay (SCSA), predicts the risk of early miscarriage after in vitro fertilization with intracytoplasmic sperm injection (IVF-ICSI). DESIGN: Retrospective cohort study of consecutive pregnancies after IVF and ICSI treatment. SETTING: Reproductive medicine center. PATIENT(S): A total of 1,602 pregnancies after 832 IVF and 770 ICSI treatments. INTERVENTION(S): HDS measured using SCSA. MAIN OUTCOME MEASURE(S): Early miscarriage (≤12 weeks). RESULT(S): The HDS represents the proportion of immature spermatozoa lacking the normal exchange of histone for protamine-complexed DNA, and the outcome parameter was early miscarriage (≤12 weeks). For all treatments, the odds ratio (OR) and 95% confidence interval (CI) for early miscarriage was 1.41 (1.07-1.85) if HDS >15% compared with HDS ≤15%. When comparing the two HDS categories, for ICSI, the OR was 1.44 (1.01-2.04) whereas for IVF the results were not statistically significant. CONCLUSION(S): There is a small but increased risk of early miscarriage if HDS >15% compared with HDS ≤15%. This increased risk is seen only after ICSI, not after IVF. These findings suggest that HDS can be used as a predictor of an increased risk of miscarriage in ICSI treatments.
OBJECTIVE: To determine whether high DNA stainability (HDS), as assessed by the sperm chromatin structure assay (SCSA), predicts the risk of early miscarriage after in vitro fertilization with intracytoplasmic sperm injection (IVF-ICSI). DESIGN: Retrospective cohort study of consecutive pregnancies after IVF and ICSI treatment. SETTING: Reproductive medicine center. PATIENT(S): A total of 1,602 pregnancies after 832 IVF and 770 ICSI treatments. INTERVENTION(S): HDS measured using SCSA. MAIN OUTCOME MEASURE(S): Early miscarriage (≤12 weeks). RESULT(S): The HDS represents the proportion of immature spermatozoa lacking the normal exchange of histone for protamine-complexed DNA, and the outcome parameter was early miscarriage (≤12 weeks). For all treatments, the odds ratio (OR) and 95% confidence interval (CI) for early miscarriage was 1.41 (1.07-1.85) if HDS >15% compared with HDS ≤15%. When comparing the two HDS categories, for ICSI, the OR was 1.44 (1.01-2.04) whereas for IVF the results were not statistically significant. CONCLUSION(S): There is a small but increased risk of early miscarriage if HDS >15% compared with HDS ≤15%. This increased risk is seen only after ICSI, not after IVF. These findings suggest that HDS can be used as a predictor of an increased risk of miscarriage in ICSI treatments.
Authors: Kamil Gill; Joanna Jakubik; Aleksandra Rosiak-Gill; Michał Kups; Mariusz Lukaszuk; Maciej Kurpisz; Monika Fraczek; Małgorzata Piasecka Journal: Int J Environ Res Public Health Date: 2019-06-05 Impact factor: 3.390
Authors: Alberto Pacheco; Arancha Blanco; Fernando Bronet; María Cruz; Jaime García-Fernández; Juan Antonio García-Velasco Journal: J Clin Med Date: 2020-12-08 Impact factor: 4.241
Authors: Jiri Rubes; Jaroslav Sipek; Vera Kopecka; Petra Musilova; Miluse Vozdova; Petra Prinosilova; Jan Topinka; Anna Pastorkova; Vlasta Svecova; Radim J Sram Journal: Health Sci Rep Date: 2021-03-09
Authors: Ruben Blachman-Braun; Jordan C Best; Victor Sandoval; Soum D Lokeshwar; Premal Patel; Taylor Kohn; Michael Jacobs; Ranjith Ramasamy Journal: F S Rep Date: 2020-08-15